Industry Research Reports
Home > Reports > Machinery & Equipment > Global BioPharma Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global BioPharma Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Machinery & Equipment
Published Date: 2025-10-21
Pages: 154 Pages
Report ld: 5188621
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global BioPharma Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global BioPharma Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Eurofins
- Pace Analytical Services
- Catalent
- Envigo
- PPD
- Element
- ALS
- Intertek
- SGS
- Boston Analytical
- EAG
- Maxxam
- ARL Bio Pharma
- West Pharmaceutical
- BioScreen
- Microbac
- RD Laboratories
- Analytical Lab Group
- Piramal Pharma Solutions
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Raw Material
- In-Process and Product
- Finished Pharmaceutical
- Others
Segment by Application
- Analytical Testing
- Drug Development Service
- Drug Packaging and Delivery
- Others
CHAPTER OUTLINE
Chapter 1: Defines the BioPharma Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to BioPharma Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global BioPharma Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Raw Material
1.2.3 In-Process and Product
1.2.4 Finished Pharmaceutical
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global BioPharma Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Analytical Testing
1.3.3 Drug Development Service
1.3.4 Drug Packaging and Delivery
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global BioPharma Service Revenue Estimates and Forecasts 2020-2031
2.2 Global BioPharma Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global BioPharma Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global BioPharma Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Raw Material Market Size by Players
3.3.2 In-Process and Product Market Size by Players
3.3.3 Finished Pharmaceutical Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global BioPharma Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global BioPharma Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global BioPharma Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America BioPharma Service Market Size by Type (2020-2031)
6.4 North America BioPharma Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America BioPharma Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe BioPharma Service Market Size by Type (2020-2031)
7.4 Europe BioPharma Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe BioPharma Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific BioPharma Service Market Size by Type (2020-2031)
8.4 Asia-Pacific BioPharma Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific BioPharma Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America BioPharma Service Market Size by Type (2020-2031)
9.4 Central and South America BioPharma Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America BioPharma Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa BioPharma Service Market Size by Type (2020-2031)
10.4 Middle East and Africa BioPharma Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa BioPharma Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins
11.1.1 Eurofins Corporation Information
11.1.2 Eurofins Business Overview
11.1.3 Eurofins BioPharma Service Product Features and Attributes
11.1.4 Eurofins BioPharma Service Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins BioPharma Service Revenue by Product in 2024
11.1.6 Eurofins BioPharma Service Revenue by Application in 2024
11.1.7 Eurofins BioPharma Service Revenue by Geographic Area in 2024
11.1.8 Eurofins BioPharma Service SWOT Analysis
11.1.9 Eurofins Recent Developments
11.2 Pace Analytical Services
11.2.1 Pace Analytical Services Corporation Information
11.2.2 Pace Analytical Services Business Overview
11.2.3 Pace Analytical Services BioPharma Service Product Features and Attributes
11.2.4 Pace Analytical Services BioPharma Service Revenue and Gross Margin (2020-2025)
11.2.5 Pace Analytical Services BioPharma Service Revenue by Product in 2024
11.2.6 Pace Analytical Services BioPharma Service Revenue by Application in 2024
11.2.7 Pace Analytical Services BioPharma Service Revenue by Geographic Area in 2024
11.2.8 Pace Analytical Services BioPharma Service SWOT Analysis
11.2.9 Pace Analytical Services Recent Developments
11.3 Catalent
11.3.1 Catalent Corporation Information
11.3.2 Catalent Business Overview
11.3.3 Catalent BioPharma Service Product Features and Attributes
11.3.4 Catalent BioPharma Service Revenue and Gross Margin (2020-2025)
11.3.5 Catalent BioPharma Service Revenue by Product in 2024
11.3.6 Catalent BioPharma Service Revenue by Application in 2024
11.3.7 Catalent BioPharma Service Revenue by Geographic Area in 2024
11.3.8 Catalent BioPharma Service SWOT Analysis
11.3.9 Catalent Recent Developments
11.4 Envigo
11.4.1 Envigo Corporation Information
11.4.2 Envigo Business Overview
11.4.3 Envigo BioPharma Service Product Features and Attributes
11.4.4 Envigo BioPharma Service Revenue and Gross Margin (2020-2025)
11.4.5 Envigo BioPharma Service Revenue by Product in 2024
11.4.6 Envigo BioPharma Service Revenue by Application in 2024
11.4.7 Envigo BioPharma Service Revenue by Geographic Area in 2024
11.4.8 Envigo BioPharma Service SWOT Analysis
11.4.9 Envigo Recent Developments
11.5 PPD
11.5.1 PPD Corporation Information
11.5.2 PPD Business Overview
11.5.3 PPD BioPharma Service Product Features and Attributes
11.5.4 PPD BioPharma Service Revenue and Gross Margin (2020-2025)
11.5.5 PPD BioPharma Service Revenue by Product in 2024
11.5.6 PPD BioPharma Service Revenue by Application in 2024
11.5.7 PPD BioPharma Service Revenue by Geographic Area in 2024
11.5.8 PPD BioPharma Service SWOT Analysis
11.5.9 PPD Recent Developments
11.6 Element
11.6.1 Element Corporation Information
11.6.2 Element Business Overview
11.6.3 Element BioPharma Service Product Features and Attributes
11.6.4 Element BioPharma Service Revenue and Gross Margin (2020-2025)
11.6.5 Element Recent Developments
11.7 ALS
11.7.1 ALS Corporation Information
11.7.2 ALS Business Overview
11.7.3 ALS BioPharma Service Product Features and Attributes
11.7.4 ALS BioPharma Service Revenue and Gross Margin (2020-2025)
11.7.5 ALS Recent Developments
11.8 Intertek
11.8.1 Intertek Corporation Information
11.8.2 Intertek Business Overview
11.8.3 Intertek BioPharma Service Product Features and Attributes
11.8.4 Intertek BioPharma Service Revenue and Gross Margin (2020-2025)
11.8.5 Intertek Recent Developments
11.9 SGS
11.9.1 SGS Corporation Information
11.9.2 SGS Business Overview
11.9.3 SGS BioPharma Service Product Features and Attributes
11.9.4 SGS BioPharma Service Revenue and Gross Margin (2020-2025)
11.9.5 SGS Recent Developments
11.10 Boston Analytical
11.10.1 Boston Analytical Corporation Information
11.10.2 Boston Analytical Business Overview
11.10.3 Boston Analytical BioPharma Service Product Features and Attributes
11.10.4 Boston Analytical BioPharma Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 EAG
11.11.1 EAG Corporation Information
11.11.2 EAG Business Overview
11.11.3 EAG BioPharma Service Product Features and Attributes
11.11.4 EAG BioPharma Service Revenue and Gross Margin (2020-2025)
11.11.5 EAG Recent Developments
11.12 Maxxam
11.12.1 Maxxam Corporation Information
11.12.2 Maxxam Business Overview
11.12.3 Maxxam BioPharma Service Product Features and Attributes
11.12.4 Maxxam BioPharma Service Revenue and Gross Margin (2020-2025)
11.12.5 Maxxam Recent Developments
11.13 ARL Bio Pharma
11.13.1 ARL Bio Pharma Corporation Information
11.13.2 ARL Bio Pharma Business Overview
11.13.3 ARL Bio Pharma BioPharma Service Product Features and Attributes
11.13.4 ARL Bio Pharma BioPharma Service Revenue and Gross Margin (2020-2025)
11.13.5 ARL Bio Pharma Recent Developments
11.14 West Pharmaceutical
11.14.1 West Pharmaceutical Corporation Information
11.14.2 West Pharmaceutical Business Overview
11.14.3 West Pharmaceutical BioPharma Service Product Features and Attributes
11.14.4 West Pharmaceutical BioPharma Service Revenue and Gross Margin (2020-2025)
11.14.5 West Pharmaceutical Recent Developments
11.15 BioScreen
11.15.1 BioScreen Corporation Information
11.15.2 BioScreen Business Overview
11.15.3 BioScreen BioPharma Service Product Features and Attributes
11.15.4 BioScreen BioPharma Service Revenue and Gross Margin (2020-2025)
11.15.5 BioScreen Recent Developments
11.16 Microbac
11.16.1 Microbac Corporation Information
11.16.2 Microbac Business Overview
11.16.3 Microbac BioPharma Service Product Features and Attributes
11.16.4 Microbac BioPharma Service Revenue and Gross Margin (2020-2025)
11.16.5 Microbac Recent Developments
11.17 RD Laboratories
11.17.1 RD Laboratories Corporation Information
11.17.2 RD Laboratories Business Overview
11.17.3 RD Laboratories BioPharma Service Product Features and Attributes
11.17.4 RD Laboratories BioPharma Service Revenue and Gross Margin (2020-2025)
11.17.5 RD Laboratories Recent Developments
11.18 Analytical Lab Group
11.18.1 Analytical Lab Group Corporation Information
11.18.2 Analytical Lab Group Business Overview
11.18.3 Analytical Lab Group BioPharma Service Product Features and Attributes
11.18.4 Analytical Lab Group BioPharma Service Revenue and Gross Margin (2020-2025)
11.18.5 Analytical Lab Group Recent Developments
11.19 Piramal Pharma Solutions
11.19.1 Piramal Pharma Solutions Corporation Information
11.19.2 Piramal Pharma Solutions Business Overview
11.19.3 Piramal Pharma Solutions BioPharma Service Product Features and Attributes
11.19.4 Piramal Pharma Solutions BioPharma Service Revenue and Gross Margin (2020-2025)
11.19.5 Piramal Pharma Solutions Recent Developments
12 BioPharma ServiceIndustry Chain Analysis
12.1 BioPharma Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 BioPharma Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global BioPharma Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global BioPharma Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global BioPharma Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global BioPharma Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global BioPharma Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global BioPharma Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global BioPharma Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global BioPharma Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global BioPharma Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BioPharma Service as of 2024)
Table 11. Global BioPharma Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global BioPharma Service Companies Headquarters
Table 13. Global BioPharma Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global BioPharma Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global BioPharma Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global BioPharma Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global BioPharma Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. BioPharma Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America BioPharma Service Growth Accelerators and Market Barriers
Table 25. North America BioPharma Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe BioPharma Service Growth Accelerators and Market Barriers
Table 27. Europe BioPharma Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific BioPharma Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific BioPharma Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America BioPharma Service Investment Opportunities and Key Challenges
Table 31. Central and South America BioPharma Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa BioPharma Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa BioPharma Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eurofins Corporation Information
Table 35. Eurofins Description and Major Businesses
Table 36. Eurofins Product Features and Attributes
Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eurofins Revenue Proportion by Product in 2024
Table 39. Eurofins Revenue Proportion by Application in 2024
Table 40. Eurofins Revenue Proportion by Geographic Area in 2024
Table 41. Eurofins BioPharma Service SWOT Analysis
Table 42. Eurofins Recent Developments
Table 43. Pace Analytical Services Corporation Information
Table 44. Pace Analytical Services Description and Major Businesses
Table 45. Pace Analytical Services Product Features and Attributes
Table 46. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Pace Analytical Services Revenue Proportion by Product in 2024
Table 48. Pace Analytical Services Revenue Proportion by Application in 2024
Table 49. Pace Analytical Services Revenue Proportion by Geographic Area in 2024
Table 50. Pace Analytical Services BioPharma Service SWOT Analysis
Table 51. Pace Analytical Services Recent Developments
Table 52. Catalent Corporation Information
Table 53. Catalent Description and Major Businesses
Table 54. Catalent Product Features and Attributes
Table 55. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Catalent Revenue Proportion by Product in 2024
Table 57. Catalent Revenue Proportion by Application in 2024
Table 58. Catalent Revenue Proportion by Geographic Area in 2024
Table 59. Catalent BioPharma Service SWOT Analysis
Table 60. Catalent Recent Developments
Table 61. Envigo Corporation Information
Table 62. Envigo Description and Major Businesses
Table 63. Envigo Product Features and Attributes
Table 64. Envigo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Envigo Revenue Proportion by Product in 2024
Table 66. Envigo Revenue Proportion by Application in 2024
Table 67. Envigo Revenue Proportion by Geographic Area in 2024
Table 68. Envigo BioPharma Service SWOT Analysis
Table 69. Envigo Recent Developments
Table 70. PPD Corporation Information
Table 71. PPD Description and Major Businesses
Table 72. PPD Product Features and Attributes
Table 73. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. PPD Revenue Proportion by Product in 2024
Table 75. PPD Revenue Proportion by Application in 2024
Table 76. PPD Revenue Proportion by Geographic Area in 2024
Table 77. PPD BioPharma Service SWOT Analysis
Table 78. PPD Recent Developments
Table 79. Element Corporation Information
Table 80. Element Description and Major Businesses
Table 81. Element Product Features and Attributes
Table 82. Element Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Element Recent Developments
Table 84. ALS Corporation Information
Table 85. ALS Description and Major Businesses
Table 86. ALS Product Features and Attributes
Table 87. ALS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. ALS Recent Developments
Table 89. Intertek Corporation Information
Table 90. Intertek Description and Major Businesses
Table 91. Intertek Product Features and Attributes
Table 92. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Intertek Recent Developments
Table 94. SGS Corporation Information
Table 95. SGS Description and Major Businesses
Table 96. SGS Product Features and Attributes
Table 97. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. SGS Recent Developments
Table 99. Boston Analytical Corporation Information
Table 100. Boston Analytical Description and Major Businesses
Table 101. Boston Analytical Product Features and Attributes
Table 102. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Boston Analytical Recent Developments
Table 104. EAG Corporation Information
Table 105. EAG Description and Major Businesses
Table 106. EAG Product Features and Attributes
Table 107. EAG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. EAG Recent Developments
Table 109. Maxxam Corporation Information
Table 110. Maxxam Description and Major Businesses
Table 111. Maxxam Product Features and Attributes
Table 112. Maxxam Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Maxxam Recent Developments
Table 114. ARL Bio Pharma Corporation Information
Table 115. ARL Bio Pharma Description and Major Businesses
Table 116. ARL Bio Pharma Product Features and Attributes
Table 117. ARL Bio Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. ARL Bio Pharma Recent Developments
Table 119. West Pharmaceutical Corporation Information
Table 120. West Pharmaceutical Description and Major Businesses
Table 121. West Pharmaceutical Product Features and Attributes
Table 122. West Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. West Pharmaceutical Recent Developments
Table 124. BioScreen Corporation Information
Table 125. BioScreen Description and Major Businesses
Table 126. BioScreen Product Features and Attributes
Table 127. BioScreen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. BioScreen Recent Developments
Table 129. Microbac Corporation Information
Table 130. Microbac Description and Major Businesses
Table 131. Microbac Product Features and Attributes
Table 132. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Microbac Recent Developments
Table 134. RD Laboratories Corporation Information
Table 135. RD Laboratories Description and Major Businesses
Table 136. RD Laboratories Product Features and Attributes
Table 137. RD Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. RD Laboratories Recent Developments
Table 139. Analytical Lab Group Corporation Information
Table 140. Analytical Lab Group Description and Major Businesses
Table 141. Analytical Lab Group Product Features and Attributes
Table 142. Analytical Lab Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Analytical Lab Group Recent Developments
Table 144. Piramal Pharma Solutions Corporation Information
Table 145. Piramal Pharma Solutions Description and Major Businesses
Table 146. Piramal Pharma Solutions Product Features and Attributes
Table 147. Piramal Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Piramal Pharma Solutions Recent Developments
Table 149. Raw Materials Key Suppliers
Table 150. Distributors List
Table 151. Market Trends and Market Evolution
Table 152. Market Drivers and Opportunities
Table 153. Market Challenges, Risks, and Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. BioPharma Service Product Picture
Figure 2. Global BioPharma Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Raw Material Product Picture
Figure 4. In-Process and Product Product Picture
Figure 5. Finished Pharmaceutical Product Picture
Figure 6. Others Product Picture
Figure 7. Global BioPharma Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Analytical Testing
Figure 9. Drug Development Service
Figure 10. Drug Packaging and Delivery
Figure 11. Others
Figure 12. BioPharma Service Report Years Considered
Figure 13. Global BioPharma Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 15. Global BioPharma Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global BioPharma Service Revenue Market Share by Region (2020-2031)
Figure 17. Global BioPharma Service Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Raw Material Revenue Market Share by Player in 2024
Figure 20. In-Process and Product Revenue Market Share by Player in 2024
Figure 21. Finished Pharmaceutical Revenue Market Share by Player in 2024
Figure 22. Others Revenue Market Share by Player in 2024
Figure 23. Global BioPharma Service Revenue Market Share by Type (2020-2031)
Figure 24. Global BioPharma Service Revenue Market Share by Application (2020-2031)
Figure 25. North America BioPharma Service Revenue YoY (2020-2031) & (US$ Million)
Figure 26. North America Top 5 Players BioPharma Service Revenue (US$ Million) in 2024
Figure 27. North America BioPharma Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 28. North America BioPharma Service Revenue (US$ Million) by Application (2020-2031)
Figure 29. US BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 30. Canada BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 31. Mexico BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 32. Europe BioPharma Service Revenue YoY (2020-2031) & (US$ Million)
Figure 33. Europe Top 5 Players BioPharma Service Revenue (US$ Million) in 2024
Figure 34. Europe BioPharma Service Revenue (US$ Million) by Type (2020-2031)
Figure 35. Europe BioPharma Service Revenue (US$ Million) by Application (2020-2031)
Figure 36. Germany BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 37. France BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 38. U.K. BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 39. Italy BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 40. Russia BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific BioPharma Service Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Top 8 Players BioPharma Service Revenue (US$ Million) in 2024
Figure 43. Asia-Pacific BioPharma Service Revenue (US$ Million) by Type (2020-2031)
Figure 44. Asia-Pacific BioPharma Service Revenue (US$ Million) by Application (2020-2031)
Figure 45. Indonesia BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 46. Japan BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 47. South Korea BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 48. Australia BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 49. India BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 50. Indonesia BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 51. Vietnam BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 52. Malaysia BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 53. Philippines BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 54. Singapore BioPharma Service Revenue (2020-2031) & (US$ Million)
Figure 55. Central and South America BioPharma Service Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Central and South America Top 5 Players BioPharma Service Revenue (US$ Million) in 2024
Figure 57. Central and South America BioPharma Service Revenue (US$ Million) by Type (2020-2031)
Figure 58. Central and South America BioPharma Service Revenue (US$ Million) by Application (2020-2031)
Figure 59. Brazil BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 60. Argentina BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 61. Middle East and Africa BioPharma Service Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Middle East and Africa Top 5 Players BioPharma Service Revenue (US$ Million) in 2024
Figure 63. South America BioPharma Service Revenue (US$ Million) by Type (2020-2031)
Figure 64. Middle East and Africa BioPharma Service Revenue (US$ Million) by Application (2020-2031)
Figure 65. GCC Countries BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 66. Israel BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 67. Egypt BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 68. South Africa BioPharma Service Revenue (2020-2025) & (US$ Million)
Figure 69. BioPharma Service Industry Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global BioPharma Service market?
The top companies in the global BioPharma Service market are Eurofins、Pace Analytical Services、Catalent.
Related Reports
BioPharma Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for BioPharma Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)
Global BioPharma Service Market Research Report 2026
The global BioPharma Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 122
USD 2900.00
(Single User License)
BioPharma Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for BioPharma Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 125
USD 3950.00
(Single User License)
Global BioPharma Service Market Research Report 2025
The global market for BioPharma Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Global BioPharma Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global BioPharma Service Market
Published Date: 2024-04-11
Pages: 114
USD 4900.00
(Single User License)
Global BioPharma Service Market Research Report 2024
The global BioPharma Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-12
Pages: 91
USD 2900.00
(Single User License)
BioPharma Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for BioPharma Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 138
USD 3950.00
(Single User License)
BioPharma Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for BioPharma Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 135
USD 3950.00 (Single User License)Global BioPharma Service Market Research Report 2026
The global BioPharma Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 122
USD 2900.00 (Single User License)BioPharma Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for BioPharma Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 125
USD 3950.00 (Single User License)Global BioPharma Service Market Research Report 2025
The global market for BioPharma Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)Global BioPharma Service Market Insights, Forecast to 2030
Market Analysis and Insights: Global BioPharma Service Market
Published: 2024-04-11
Pages: 114
USD 4900.00 (Single User License)Global BioPharma Service Market Research Report 2024
The global BioPharma Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-12
Pages: 91
USD 2900.00 (Single User License)BioPharma Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for BioPharma Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 138
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now